Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 444666-46-0 | MDL No. : | MFCD04115058 |
Formula : | C13H18N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KKBYAYOFCRJQQT-UHFFFAOYSA-N |
M.W : | 234.29 | Pubchem ID : | 22507589 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.46 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 73.34 |
TPSA : | 41.57 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.74 cm/s |
Log Po/w (iLOGP) : | 2.66 |
Log Po/w (XLOGP3) : | 1.4 |
Log Po/w (WLOGP) : | 0.7 |
Log Po/w (MLOGP) : | 1.41 |
Log Po/w (SILICOS-IT) : | 1.42 |
Consensus Log Po/w : | 1.52 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.17 |
Solubility : | 1.58 mg/ml ; 0.00673 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.88 |
Solubility : | 3.11 mg/ml ; 0.0133 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -3.15 |
Solubility : | 0.165 mg/ml ; 0.000705 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.64 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H319 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50.4% | With sodium hydroxide In water; butan-1-ol at 23 - 26℃; for 2 h; | Comparative Example 5 A 200 ml four-neck flask with a pH meter and dropping funnel was charged with 10.02 g (= 0.100 mole) of racemic 2-methylpiperazine, and 80.2 g of 1-butanol was added for dissolution, being followed by addition of 20.1 g of water (water content 20.0 wtpercent). With vigorous stirring, benzyl chlorocarbonate was added dropwise. In this case, 48 wtpercent sodium hydroxide aqueous solution was added dropwise to keep the pH value of the system at 7.5 to 8.5, and as required, the system was cooled with ice to keep the internal temperature at 23 to 26 (final water content 23.0 wtpercent). After completion of dropwise addition, with vigorous stirring, aging was carried out for 2 hours. The reaction solution was sampled and analyzed, and as a result, the reaction yield of 1-benzyloxycarbonyl-2-methylpiperazine was 50.4percent. |
40.1% | With sodium hydroxide In water; butan-1-ol at 23 - 26℃; for 2 h; | Comparative Example 4 A 200 ml four-neck flask with a pH meter and dropping funnel was charged with 10.02 g (= 0.100 mole) of racemic 2-methylpiperazine, and 50.0 g of 1-butanol was added for dissolution, being followed by addition of 50.1 g of water (water content 50.0 wtpercent). With vigorous stirring, benzyl chlorocarbonate was added dropwise. In this case, 48 wtpercent sodium hydroxide aqueous solution was added dropwise to keep the pH value of the system at 10 to 11, and as required, the system was cooled with ice to keep the internal temperature at 23 to 26°C (final water content 52.1 wtpercent). After completion of dropwise addition, with vigorous stirring, aging was carried out for 2 hours. The reaction solution was sampled and analyzed, and as a result, the reaction yield of 1-benzyloxycarbonyl-2-methylpiperazine was 40.1percent. |
[ 1217720-49-4 ]
(S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 1217831-52-1 ]
(R)-Benzyl 3-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 128102-16-9 ]
(R)-4-Benzyl 1-Boc-2-methylpiperazine-4-carboxylate
Similarity: 0.95
[ 191739-40-9 ]
4-N-Cbz-(2-Hydroxymethyl)piperazine
Similarity: 0.93
[ 1217720-49-4 ]
(S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 1217831-52-1 ]
(R)-Benzyl 3-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 128102-16-9 ]
(R)-4-Benzyl 1-Boc-2-methylpiperazine-4-carboxylate
Similarity: 0.95
[ 191739-40-9 ]
4-N-Cbz-(2-Hydroxymethyl)piperazine
Similarity: 0.93
[ 1217720-49-4 ]
(S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 1217831-52-1 ]
(R)-Benzyl 3-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 128102-16-9 ]
(R)-4-Benzyl 1-Boc-2-methylpiperazine-4-carboxylate
Similarity: 0.95
[ 191739-40-9 ]
4-N-Cbz-(2-Hydroxymethyl)piperazine
Similarity: 0.93
[ 1217720-49-4 ]
(S)-Benzyl 2-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 1217831-52-1 ]
(R)-Benzyl 3-methylpiperazine-1-carboxylate hydrochloride
Similarity: 0.98
[ 128102-16-9 ]
(R)-4-Benzyl 1-Boc-2-methylpiperazine-4-carboxylate
Similarity: 0.95
[ 191739-40-9 ]
4-N-Cbz-(2-Hydroxymethyl)piperazine
Similarity: 0.93
[ 31166-44-6 ]
Benzyl piperazine-1-carboxylate
Similarity: 0.93